Document is current
Any future updates will be listed below
-
Authors
,
Uemura, Yukari https://orcid.org/0000-0002-3013-7775
Tanaka, Shiro
Miyazaki, Teruhiko
Tsukiyama, Mayumi
Sone, Teruki
Taguchi, Akira
Soen, Satoshi
Mori, Satoshi
Hagino, Hiroshi
Sugimoto, Toshitsugu
Fukunaga, Masao
Ohta, Hiroaki
Nakamura, Toshitaka
Orimo, Hajime
Shiraki, Masataka
-
Funding
Funding for this research was provided by:
Public Health Research Foundation
Japan Agency for Medical Research and Development (17lk0201061h0002)
- License Information
-
More Information
Article History
Received: 1 June 2018
Accepted: 28 June 2018
First Online: 17 July 2018
Compliance with ethical standards
:
: YU has received a consultancy fee from Teijin Pharma. ST has received lecture fees from Astra-Zeneca, Taiho, and Ono. He has received consultation fees from DeNA Life Science and CanBus. He has received outsourcing fees from Satt and Asahi Kasei Pharma. His wife has been engaged in a research project of Bayer. TM and MT are employees of the Public Health Research Foundation. TS has received research grants from Asahi Kasei Pharma, Astellas Pharma, Daiichi-Sankyo, Taisho Toyama Pharmaceutical, Takeda Pharmaceutical, Pfizer and Teijin Pharma, and consulting fees from Daiichi-Sankyo and Takeda Pharmaceutical. AT received consultancy or lecture fees from Asahi Kasei, Teijin, Ono, Chugai, Takeda, and Daiichi-Sankyo pharma. SS received lecture and consultancy fees from Asahikasei Pharmaceutical Co., Astellas Pharma, Chugai Pharmaceutical Co., Daiichi Sankyo Co., Eisai Co., Eli Lilly Japan, Ono Pharmaceutical Co., Pfizer Co., Takeda Pharmaceutical Co. HH has received lecture and consultancy fees from Asahi Kasei Pharma Corp., Astellas Pharma Inc., MSD Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Pfizer Co., Ltd., Mitsubishi Tanabe Pharma Corp., Mochida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Pfizer Inc., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. ToS has received research grants from Astellas Pharma, Eisai, Daiichi-Sankyo, Chugai Pharmaceutical and Eli Lilly Japan as well as consulting and/or lecture fees from Asahi Kasei Pharma, MSD and Daiichi-Sankyo. MF received consulting fees from Asahi Kasei Pharma and lecture fees from Daiichi-Sankyo, MSD, and Chugai Parma. HO received fees from Phizer co.jp. MS received lecture and consultancy fees from Asahikasei Pharma and Teijin Pharma.
